ProCE Banner Activity

What Can We Learn From GLP-1 Receptor Agonist Studies on Weight Loss?

Clinical Thought
Read my answers to healthcare professionals’ questions about starting and stopping incretins in patients needing weight loss.

Released: May 04, 2021

Expiration: May 03, 2022

Share

Faculty

Jenny Tong

Jenny Tong, MD, MPH

Associate Professor
Division of Metabolism, Endocrinology and Nutrition
University of Washington
VA Puget Sound Health Care Systems
Seattle, Washington

Provided by

Provided by the Endocrine Society, in collaboration with Clinical Care Options.
ProCE Banner

Supporters

Supported by an educational grant from

Novo Nordisk Inc

Faculty Disclosure

Primary Author

Jenny Tong, MD, MPH

Associate Professor
Division of Metabolism, Endocrinology and Nutrition
University of Washington
VA Puget Sound Health Care Systems
Seattle, Washington

Jenny Tong, MD, MPH, has no relevant conflicts of interest to report.